Kyowa Kirin Co., Ltd.
General ticker "KYKOF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $8.2B (TTM average)
Kyowa Kirin Co., Ltd. follows the US Stock Market performance with the rate: 7.8%.
Estimated limits based on current volatility of 1.3%: low 12.14$, high 12.46$
Factors to consider:
- Company pays dividends (annually): last record date 2025-12-31, amount 0.16$ (Y1.29%)
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [11.77$, 19.13$]
- 2025-12-31 to 2026-12-31 estimated range: [13.10$, 20.76$]
Financial Metrics affecting the KYKOF estimates:
- Positive: with PPE of 20.2 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 18.54 > 18.38
- Negative: 0.01 < Interest expense per share per price, % of 0.60
- Negative: Industry operating cash flow per share per price (median), % of 8.11 <= 10.29
- Positive: Inventory ratio change, % of -1.07 <= -0.75
- Positive: -14.22 < Investing cash flow per share per price, % of -11.32
- Negative: Operating cash flow per share per price, % of 5.40 <= 6.64
- Positive: Return on assets ratio (scaled to [-100,100]) of 7.25 > 6.11
Short-term KYKOF quotes
Long-term KYKOF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | ¥442,233.00MM | ¥495,558.00MM | ¥497,259.54MM |
| Operating Expenses | ¥355,794.00MM | ¥403,692.00MM | ¥394,895.29MM |
| Operating Income | ¥86,439.00MM | ¥91,866.00MM | ¥102,364.25MM |
| Non-Operating Income | ¥10,807.00MM | ¥-8,413.00MM | ¥-15,067.14MM |
| Interest Expense | ¥190.00MM | ¥7,538.00MM | ¥3,647.18MM |
| R&D Expense | ¥81,509.00MM | ¥103,544.00MM | ¥101,271.29MM |
| Income(Loss) | ¥97,246.00MM | ¥83,453.00MM | ¥87,297.11MM |
| Taxes | ¥16,058.00MM | ¥0.00MM | ¥20,199.61MM |
| Profit(Loss)* | ¥81,188.00MM | ¥59,870.00MM | ¥67,098.50MM |
| Stockholders Equity | ¥836,418.00MM | ¥850,811.00MM | ¥894,111.53MM |
| Inventory | ¥71,363.00MM | ¥72,933.00MM | ¥67,498.85MM |
| Assets | ¥1,025,942.00MM | ¥1,067,363.00MM | ¥1,108,826.73MM |
| Operating Cash Flow | ¥115,551.00MM | ¥67,884.00MM | ¥100,103.27MM |
| Capital expenditure | ¥32,852.00MM | ¥105,268.00MM | ¥41,147.88MM |
| Investing Cash Flow | ¥-20,382.00MM | ¥-142,389.00MM | ¥-92,666.79MM |
| Financing Cash Flow | ¥-32,535.00MM | ¥-84,697.00MM | ¥-36,885.16MM |
| Earnings Per Share** | ¥151.01 | ¥113.06 | ¥128.18 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.